ArticleInsights into imaging2025
Harnessing routine MRI for the early screening of Parkinson's disease: a multicenter machine learning study using T2-weighted FLAIR imaging.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Interpretable machine learning for Parkinson's disease diagnosis, staging, and biological mechanism exploration: a multicenter analysis.BioData mining · 2026Article
- Machine learning-based radiomics modeling of combined subcortical nuclei from quantitative susceptibility mapping for Parkinson's disease diagnosis.Frontiers in aging neuroscience · 2026Article
- Attention-based Transformer-LSTM architecture for early diagnosis and staging of early-stage Parkinson's disease using fNIRS data.Frontiers in aging neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo explore the potential of radiomics features derived from T2-weighted fluid-attenuated inversion recovery (T2W FLAIR) images to distinguish idiopathic Parkinson's disease (PD) patients from healthy controls (HCs).
methodsT2W FLAIR images from 1727 subjects were retrospectively obtained from five cohorts and divided into a training set (395 PD/574 HC), an internal test set (99 PD/144 HC) and an external test set (295 PD/220 HC). Regions of interest (ROIs), including bilateral globus pallidus (GP), putamen (PU), substantia nigra (SN), and red nucleus (RN), were manually delineated. The radiomics features were extracted from ROIs. Six independent machine learning (ML) classifiers were trained on the training set, and validated on the internal and external test sets.
resultsA selection of five, two, three, and ten highly correlated diagnostic features were identified from SN, RN, GP, and PU regions, respectively. Six ML classifiers were implemented based on the combined 20 radiomics features. In the internal test cohort, the six models achieved AUC of 0.96-0.98 with the accuracy ranging from 0.80 to 0.90. In the external test cohort, the multilayer perceptron model demonstrated the highest AUC of 0.85 (95% CI: 0.80-0.89) with an accuracy of 0.78.
conclusionML models based on the conventional T2W FLAIR images demonstrated promising diagnostic performance for PD and those models may serve as a basis for future investigations on PD diagnosis with the aid of ML methods. CRITICAL RELEVANCE STATEMENT: Our study confirmed that early screening of Parkinson's Disease based on the conventional T2W FLAIR images was feasible with the aid of machine learning algorithms in a large multicenter cohort and those models had certain generalization. KEY POINTS: Conventional head MRI is routinely performed in Parkinson's disease (PD) but exhibits inadequate specificity for diagnosis. Machine learning (ML) models based on conventional T2W FLAIR images showed favorable accuracy for PD diagnosis. ML algorithm enables early screening of PD on routine T2W FLAIR sequence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.